About

The human Inflammatory Bowel Diseases (IBDs), Crohn’s disease (CD) and ulcerative colitis (UC) affect 3 million Americans. The overall incidence of the IBDs is increasing for unknown reasons. There is no cure for IBD: Consequently, the chronic nature of IBD is therefore a steadily increasing burden on the healthcare system. Current medical and surgical approaches are insufficient for many IBD patients who endure attempts at trying different combinations of therapies over their entire life. As a physician-scientist I am dedicated to the care of people with IBD while actively pursuing research that contributes to our understanding of Crohn’s disease (CD) and ulcerative colitis (UC), with the ultimate goal of finding a cure. To accomplish these goals we have developed projects that bridge our work in animal models of IBD to human IBD with advanced technologies in epithelial cell biology, immunology, microbiology, molecular biology and high throughput genomics.